Lunit and Labcorp Announce Strategic Collaboration to Advance AI-Powered Digital Pathology Research

Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and precision oncology, and Labcorp, a global ...

Blastic Plasmacytoid Dendritic Cell Neoplasm Market Research and Forecast Report 2025-2035: CD123-Targeted Therapies Emerge as the Leading Opportunity, Driven by ADCs, CAR-T ...

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive hematologic malignancy classified by WHO and marked by cutaneous lesions, bone marrow infiltration, and CNS involvement.
ascopubs.org

Development and Evaluation of Perl-Based Algorithms to Classify Neoplasms From Pathology Records in Synoptic Report Format

The specificity of the Perl-based algorithms was consistently high, over 98%. Very few benign results were classified as malignant or in situ by the Perl-based algorithms; the leukemia algorithm ...

PathAI Announces Self-Service Integration of PathExplore on AISight to Advance Tumor Microenvironment Analysis

PathExplore is designed to deliver a structured, standardized, and scalable panel of human interpretable features (HIFs) from H&E whole-slide images. Powered by PathAI’s next-generation foundation ...

AI-assisted immune profiling helps predict treatment success in rectal cancer patients

Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard ...